SARS-CoV-2 3CLpro-IN-20

CAS No. 878985-00-3

SARS-CoV-2 3CLpro-IN-20( —— )

Catalog No. M37021 CAS No. 878985-00-3

SARS-CoV-2 3CLpro-IN-20 is a covalent inhibitor of SARS-CoV-2 3CLpro with an IC50 of 0.43 μM and potential antiviral activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 36 Get Quote
10MG 59 Get Quote
25MG 90 Get Quote
50MG 136 Get Quote
100MG 196 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    SARS-CoV-2 3CLpro-IN-20
  • Note
    Research use only, not for human use.
  • Brief Description
    SARS-CoV-2 3CLpro-IN-20 is a covalent inhibitor of SARS-CoV-2 3CLpro with an IC50 of 0.43 μM and potential antiviral activity.
  • Description
    SARS-CoV-2 3CLpro-IN-20 (Compound 5g) is a covalent SARS-CoV-2 3CLpro inhibitor (IC50s: 0.43 μM, Ki: ?0.33?μM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    Antiviral
  • Recptor
    Antiviral | SARS-CoV
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    878985-00-3
  • Formula Weight
    366.21
  • Molecular Formula
    C19H12BrNO2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 4.76 mg/mL (13.00 mM; Ultrasonic (<60°C)
  • SMILES
    C(N1C=2C(C(=O)C1=O)=CC(Br)=CC2)C3=CC4=C(C=C3)C=CC=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Bao HL, et al. Design and synthesis of isatin derivatives as effective SARS-CoV-2 3CL protease inhibitors. Chem Biol Drug Des. 2023 Aug 10.
molnova catalog
related products
  • 5-Fluorocytidine

    5-Fluorocytidine with antiviral activity.

  • Arbidol

    Umifenovir is a potent, orally active broad-spectrum antiviral agent with activity against enveloped and non-enveloped viruses, suppressing virus propagation and modulating the expression of inflammatory cytokines for use as an anti-influenza virus agent .

  • WIN 54954

    WIN 54954 is an orally available antiviral agent that inhibits Coxsackievirus and inhibits viral translation or transcription.